INTERVIEWS

Guest: Dr. Michael Greger
Presenter: Neal Howard
Guest Bio: Michael Greger, MD, is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. Currently Dr. Greger serves as the Director of Public Health and Animal Agriculture at The Humane Society of the United States. His latest book How Not to Die became an instant New York Times Best Seller.

Segment overview: Michael Greger, MD, FACLM, and author of the New York Times best seller “How Not To Die”, discusses his other writings, and whats trending now in nutrition research.

Guest: Dr. Michael Greger
Presenter: Neal Howard
Guest Bio: Michael Greger, MD, is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. Currently Dr. Greger serves as the Director of Public Health and Animal Agriculture at The Humane Society of the United States. His latest book How Not to Die became an instant New York Times Best Seller.

Segment overview: Michael Greger, MD, FACLM, and author of the New York Times best seller “How Not To Die”, talks about Nutritionfacts.org, a non profit organization that he founded.

Guest: Dr. Michael Greger
Presenter: Neal Howard
Guest Bio: Michael Greger, MD, is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. Currently Dr. Greger serves as the Director of Public Health and Animal Agriculture at The Humane Society of the United States. His latest book How Not to Die became an instant New York Times Best Seller.

Segment overview: Michael Greger, MD, FACLM, discusses his latest book, a New York Times best seller, “How Not To Die” that takes a look at the 15 top causes of death in America, and how nutritional and lifestyle interventions that are peer-reviewed and scientifically proven can help.

Guest: Dr. Alan Taylor
Presenter: Patrick Reyes
Guest Bio: Dr Alan Taylor has a background as a scientist, investment banker, entrepreneur and investor. Alan is currently very active in the Australian start-up area, investing in, advising and taking an active role within a number of early stage companies. Alan is also the Chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company in the transport and logistics area. Alan is passionate about the commercialisation of Australian science and technologies, either in general technology or the life sciences. Alan has approximately 10 years of investment banking experience, and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. He has experience across a broad range of industries including healthcare and life sciences, technology, and resources. At Inteq, Alan was involved in some of Australia’s largest life sciences transactions. Alan is also a lecturer at the University of Sydney, lecturing to Masters of Commerce and International Business students undertaking studies in New Business Opportunities and Start-ups.

Segment overview: In today’s Health Supplier Segment, we welcome Dr. Alan Taylor who is currently the Executive Chairman at Clarity Pharmaceuticals. Their technology, developed in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) and the University of Melbourne, allows biopharmaceuticals to be radiolabelled for therapy as well as visualised using PET imaging. The imaging data generated provides powerful information on targeting, clearance and biodistribution of the product, which aids in drug development. This de-risks the development process and allows making informed decisions regarding biopharmaceutical drug candidates. Clarity offers this capability as a service to biopharmaceutical developers worldwide and also utilises the expertise to develop its own clinical pipeline. The company’s in-house drug development program is focused on developing novel targeted therapeutics, along with their companion diagnostics, to treat serious disease. Clarity’s first product, SARTATE™, is being developed to treat a range of cancers including neuro-endocrine tumours, as well as devastating childhood cancers such as neuroblastoma and medulloblastoma.

Guest: Dr. Iraj Ghadiminejad
Presenter: Wayne Bucklar
Guest Bio: Iraj Ghadiminejad is the managing director of GNP Australia Pty Ltd. He was educated in England with a PhD in Autoimmunity from Kings College London. Prior to immigrating to Australia he worked at St Mary’s Hospital, London UK. In Australia he was the head of Renal Research at the Children’s hospital Sydney. He left the hospital in order to set up a biotech company for the development of therapeutic products for the treatment of immune related conditions.

Segment overview: In today’s Health Supplier Segment, we are joined by managing director Dr. Iraj Ghadiminejad of GNP Australia Pty Ltd to discuss their products called ENDOR which are based on a discovery of an active compound from children with an over active immune response. They are an Australian pharmaceutical company dedicated to developing products for the treatment of chronic conditions. Their mission is to develop products that are effective in treating patients without harmful side effects. ENDOR cream has been formulated so that it is easily absorbed through the skin barrier and delivers the base ingredients to the active compound. The person’s own body will then convert these base ingredients into the active compound, which in turn calms the overactive immune response.

Guest: Tristan White
Presenter: Wayne Bucklar
Guest Bio: Smart Company has described Tristan White as “one of Australia’s next generation of business leaders.”
Tristan is married to Kimberley and dad to Alexandra & Harriet. He’s a qualified physiotherapist and is best known as the founder and CEO of The Physio Co. Tristan’s passion is building The Physio Co to have a strong family-like culture. The simple approach of being honest, treating people with the respect they deserve and doing it all with a smile is working for Tristan and his TPC team!
Tristan loves to share what he’s learnt. His Culture is Everything blog was listed as one of Australia’s 20 Best Business Blogs in 2011, 2013 and 2014. Tristan is regularly a keynote speaker at conferences where he shares his engaging presentations including ‘The 4 Secrets to Building a World Class Culture’ & ‘Blogging for Business’. Tristan believes that Culture is Everything to business success. With his progress so far it seems to be working.

Segment overview: In today’s Health Supplier Segment, we welcome Founder and CEO of The Physio Co Tristan White. They improve the quality of life for thousands of Australian seniors in aged care facilities, residential villages and in their own homes. They provide great attention to detail, outstanding customer service and ongoing quality assurance programs. In 2014, The Physio Co was named No. 1 on BRW’s list of Australia’s 50 Best Places to Work. With this award, The Physio Co has been in Australia’s Top 50 Places to Work for 6 consecutive years in it’s 10 year history.

Guest: Scott Sheppard
Presenter: Wayne Bucklar
Guest Bio: Scott Sheppard is the Executive General Manager of House with No Steps in Queensland & Northern New South Wales. Scott has worked in the Disability Services sector for over 20 years.

Segment overview: In today’s Health Supplier Segment, we are joined by Executive General Manager of House with No Steps in Queensland and Northern New South Wales Scott Sheppard to share insightful information regarding their wide range of services. They focus on enabling people with a disability to realise their personal aspirations and goals. Their disability services offer support for people with a disability to realise their dreams, whether that means moving out of home, finding a job, or being active.

Guest: Dr. Ara Dikranian
Presenter: Neal Howard
Guest Bio: Dr. Ara Dikranian has been with SDAMC since 2004. He received his Bachelor of Science degree in psychobiology in 1991 and his medical degree in 1995, both from the University of Southern California. He is the current chair of the Arthritis Foundation San Diego chapter advisory board and volunteers his time for uninsured patients through the San Diego County Medical Association Foundation Project Access program.

Segment overview: Dr. Ara Dikranian of San Diego Arthritis Medical Clinic, and member of the RA NarRAtive Advisory Panel, discusses what’s next for the RA NarRAtive Initiative, supported by Pfizer.

Guest: Dr. Ara Dikranian
Presenter: Neal Howard
Guest Bio: Dr. Ara Dikranian has been with SDAMC since 2004. He received his Bachelor of Science degree in psychobiology in 1991 and his medical degree in 1995, both from the University of Southern California. He is the current chair of the Arthritis Foundation San Diego chapter advisory board and volunteers his time for uninsured patients through the San Diego County Medical Association Foundation Project Access program.

Segment overview: Dr. Ara Dikranian of San Diego Arthritis Medical Clinic, and member of the RA NarRAtive Advisory Panel, talks about the findings from the RA NarRAtive patient survey that demonstrate a disconnect between patients and physicians across multiple aspects of RA disease management.

Guest: Dr. Ara Dikranian
Presenter: Neal Howard
Guest Bio: Dr. Ara Dikranian has been with SDAMC since 2004. He received his Bachelor of Science degree in psychobiology in 1991 and his medical degree in 1995, both from the University of Southern California. He is the current chair of the Arthritis Foundation San Diego chapter advisory board and volunteers his time for uninsured patients through the San Diego County Medical Association Foundation Project Access program.

Segment overview: Dr. Ara Dikranian of San Diego Arthritis Medical Clinic, member of the RA NarRAtive Advisory Panel, discusses rheumatoid arthritis and the RA NarRAtive patient survey that was conducted by Harris Poll on behalf of Pfizer.